chr6-28126896-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_025231.3(ZSCAN16):āc.501G>Cā(p.Gln167His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000209 in 1,581,490 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_025231.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZSCAN16 | NM_025231.3 | c.501G>C | p.Gln167His | missense_variant | 3/4 | ENST00000340487.5 | |
ZSCAN16-AS1 | NR_103456.1 | n.573-3685C>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZSCAN16 | ENST00000340487.5 | c.501G>C | p.Gln167His | missense_variant | 3/4 | 1 | NM_025231.3 | P1 | |
ZSCAN16-AS1 | ENST00000660873.1 | n.77+9849C>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000207 AC: 5AN: 241424Hom.: 0 AF XY: 0.0000306 AC XY: 4AN XY: 130632
GnomAD4 exome AF: 0.0000196 AC: 28AN: 1429306Hom.: 0 Cov.: 30 AF XY: 0.0000324 AC XY: 23AN XY: 710748
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2023 | The c.501G>C (p.Q167H) alteration is located in exon 3 (coding exon 2) of the ZSCAN16 gene. This alteration results from a G to C substitution at nucleotide position 501, causing the glutamine (Q) at amino acid position 167 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at